Clinical Trial Update: PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating multiple dose regimens of MT-3724 with gemcitabine and oxaliplatin in relapsed/refractory diffuse large B-cell lymphoma; study terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• MT-3724
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Molecular Templates, Inc. | Conditions: Non-hodgkin Lymphoma,B Cell, Refractory Diffuse Large B-Cell Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2022-08-16